Crosser iQ CTO Recanalization System— 510(k) K203363

Substantially Equivalent

C.R. Bard, Inc.

FDA 510(k) clearance K203363 for Crosser iQ CTO Recanalization System, Substantially Equivalent on 2021-08-12. Applicant: C.R. Bard, Inc..

Clearance details

Applicant
C.R. Bard, Inc.
Product code
Code PDU
Advisory panel
Cardiovascular
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Tempe, AZ, US
Download summary PDFView on FDA.gov ↗

Adverse events under product code PDU

product code PDU
Malfunction
793
Total
793

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.